Blocking C5L2 decreased C5a-primed neutrophils for ANCA-induced degranulation. by Jian Hao (160736)

Changes associated with kidney fibrosis and effects of MN705 treatment on TGF- by Wencheng Jin (13136262)

Subjects:

Blocking C5L2 decreased MPO concentration in the supernatant of C5a-primed neutrophils. by Jian Hao (160736)

HIF-1α knockdown and TGF-β blockade decreases VEGF and CXCR4 mRNA expression <i>in vitro</i>. by Lauren K. Dunn (260121)

The human neutrophil IL-1β secretory response, in contrast to the CXCL8/IL-8 secretory response decreases as MOI increases. by Florencia Sabbione (4862455)

The screening process of MN705. by Wencheng Jin (13136262)

Subjects:

Changes of anti-oxidative enzyme and oxidative stress after in a mouse model of kidney fibrosis. by Wencheng Jin (13136262)

Subjects:

Changes related to kidney staining in UUO mouse model. by Wencheng Jin (13136262)

Subjects:

Changes associated with kidney fibrosis in TGF- by Wencheng Jin (13136262)

Subjects:

Validation of MN705 treatment effects in human proximal tubular epithelial cells during TGF- by Wencheng Jin (13136262)

Subjects:

Effect of MN705 treatment on TGF- by Wencheng Jin (13136262)

Subjects:

Plot of mean compassion satisfaction by group and time. by Kunal Desai (18784208)

TNF-α inhibited A549 cell viability, increased paracellular permeability, HIF-1α expression and decreased VASP expression. by Mengjie Tang (602523)

Decreased levels of NMDAR2B in the synaptic plasma membrane of spinal cord of CCI-mice treated with compound 30 at 56 dpi. by Xavier Xifró (719821)

Exogenous IL-15 decreases the fraction but not the absolute number of CD25^High CD4⁺ T cells. by Tom L. Van Belle (306406)

rAd-p53 induces apoptosis in HCC cell lines with increased Fbxw7 and decreased c-Myc and Cyclin E. by Kangsheng Tu (428934)

“…<p>A) MTT activity was measured after infecting Hep3B cells with rAd-p53 in an MOI gradient to determine their IC₅₀ after 48 h. Mean OD values were used to calculate the IC₅₀ via the modified Kou-type method: lgIC₅₀ = Xm-I (P-(3-Pm-Pn)/4), in which Xm: lg maximum dose; I: lg (maximum dose/ adjacent dose); P: sum of positive response rate; Pm: the largest positive response rate; Pn: the smallest positive response rate. …”

Cdk5 inhibition by olomoucine prevents the fragmentation of the Golgi and decreases Tau secretion. by Nguyen-Vi Mohamed (323606)

The M77K mutation decreases the calcium-induced activation of Nox5. by Yusi Wang (592335)

Administration of APB5, but not APA5, decreases the hyperplasia of alveolar type 2 epithelial cells induced by BLM. by Masami Kishi (6167105)

“…The administration of APB5 markedly decreased the hyperplasia of type 2 epithelial cells induced by BLM. …”

LY5 inhibits pSTAT3 in sarcoma cell lines. by Peter Y. Yu (4281448)